The Technology Co.,Ltd.

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
488 ^KRW	0.00%		-1.41%	-23.75%

Mar. 22	PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	CI
Mar. 21	PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	CI

PharmswellBio Co., Ltd. announced that it has received KRW 6 billion in funding

February 21, 2019

On February 22, 2019, PharmswellBio Co., Ltd. (KOSDAQ:A043090) closed the transaction.

Latest news about The Technology Co.,Ltd.

PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	Mar. 21	CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	Mar. 20	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding	23-08-17	CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-05-02	CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-04-25	CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding	23-03-15	CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc	22-10-16	CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering	22-08-04	MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.	22-08-04	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc	22-08-03	CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.	21-12-26	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.	21-10-28	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-20	CI
Hanju Chemical & Holdings Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-18	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 17.49999934 billion in funding from Jaanh Cosmetics, Inc.	21-06-15	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 12.49999978 billion in funding from CHOROKBAEM COMPANY Co., Ltd.	21-03-28	CI
PharmswellBio Co., Ltd. announced that it has received KRW 4.999997086 billion in funding from Cube Partners, C.S. Global Co., Ltd.	19-09-23	CI
PharmswellBio Co., Ltd.(KOSDAQ:A043090) dropped from S&P Global BMI Index	19-09-23	CI

The Technology Co Ltd, formerly Exergy21 Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company manly operates its business through four segments. The Distribution Business segment engages in the food processors, luxury goods, healthy food, kitchen appliances and home shopping goods distribution business. The PM business segment provides consulting services for real estate development, licensing, and contractor selection. The Pharmaceutical segment engages in ethanol and disinfectant manufacture business. The Other segment provides business support services. The Company also engages in information technology (IT) services, artificial intelligence (AI) and drone based security solutions, as well as heat pump system provision business.

Sector

Industrial Machinery & Equipment

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Industrial Machinery & Equipment Wholesale

	1st Jan change	Capi.
THE TECHNOLOGY CO.,LTD.	-23.75%	24.5M
W.W. GRAINGER, INC.	+15.77%	46.98B
APPLIED INDUSTRIAL TECHNOLOGIES, INC.	+9.40%	7.32B
DIPLOMA PLC	-1.56%	5.98B
MSC INDUSTRIAL DIRECT CO., INC.	-9.83%	5.2B
DNOW INC.	+31.45%	1.63B
DISTRIBUTION SOLUTIONS GROUP, INC.	+2.76%	1.54B
BUFAB AB	+0.98%	1.4B
TRUSCO NAKAYAMA CORPORATION	-1.19%	1.04B
MRC GLOBAL INC.	+7.77%	1.02B